Skip to main content

Table 2 Score of tissue damage in GvHD target organs in the different treatment groups

From: Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

  

Skin

Large intestine

Liver

Third week post-transplantation

GvHD

2

3

1

GvHD + BEZ235

2

1

1

>60-day post-transplantation

GvHD

2

2

1

GvHD + BEZ235

0

0

0,5